Search

Author/Creator Dockens, Randy

1. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012)

Authors:
Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy
Journal:
British journal of clinical pharmacology
Issue:
Volume 75:Number 1(2013:Jan.)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012)

Authors:
Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy
Journal:
British journal of clinical pharmacology
Issue:
Volume 75:Number 1(2013:Jan.)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects. Issue 4 (19th February 2022)

Authors:
Chimalakonda, Anjaneya; Singhal, Shalabh; Darbenzio, Raymond; Dockens, Randy; Marchisin, David; Banerjee, Subhashis; Girgis, Ihab G.; Throup, John; He, Bing; Aras, Urvi; Murthy, Bindu
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 4(2022)
Page Start:
442
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗